Alpenglow Biosciences has filed a notice of an exempt offering of securities to raise $4,850,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Alpenglow Biosciences is raising up to $4,850,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nicholas Reder played a…